{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-065979","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2025-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.883718+00:00","generated_at":"2026-05-18T09:15:44.172417+00:00","sec_items":["1.01","1.02","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Pacira enters $300M revolving credit facility, replaces prior term loan A","bullets":["$300M senior secured revolver matures July 3, 2030; includes $10M LC sublimit and $15M swingline.","Proceeds used to repay and terminate existing term loan A facility; no prepayment penalties.","Interest rates: SOFR + 2.50%-3.25% or base rate + 1.50%-2.25%, based on leverage ratio.","Facility secured by substantially all assets of Pacira and subsidiary guarantors.","Incremental facility capacity up to greater of $225M or 100% Consolidated EBITDA."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-065979","json":"https://secwatch.observer/filing/0001104659-25-065979.json","markdown":"https://secwatch.observer/filing/0001104659-25-065979.md","text":"https://secwatch.observer/filing/0001104659-25-065979.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000110465925065979/0001104659-25-065979-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000110465925065979/tm2519804d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:15:44.172417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}